Bristol-Myers Squibb Company 13D and 13G filings for Ikena Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 4:05 pm Unchanged |
2024-09-30 | 13G | Ikena Oncology, Inc. IKNA |
BRISTOL MYERS SQUIBB CO BMY |
2,133,142 4.400% |
0 (Unchanged) |
Filing |
| 2021-04-05 5:25 pm Purchase |
2021-03-25 | 13G | Ikena Oncology, Inc. IKNA |
BRISTOL MYERS SQUIBB CO BMY |
2,133,142 5.900% |
2,133,142 (New Position) |
Filing |